Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Eli Lilly's New Compliance Chief on His Priorities
2 Eli Lilly and Kumquat Seek Enhanced Tumor-Specific Immune Response in $2B+ Deal
3 Gunning for Biogen's multibillion dollar market, Eli Lilly cuts up another batch of Alzheimer's data
4 Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance
5 Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?
6 Eli Lilly teams up with KRAS drug pioneer Yi Liu targeting small molecule I/O with $70M upfront
7 Eli Lilly & Co. stock falls Thursday, underperforms market
8 Eli Lilly (LLY) Gains As Market Dips: What You Should Know
9 Lilly to acquire biotech company Protomer Technologies
10 Eli Lilly, Kumquat in immuno-oncology collaboration potentially worth more than $2B
11 Eli Lilly and Incyte's Baricitinib Receives FDA EUA for Use as Monotherapy in Hospitalized COVID-19 Patients Requiring Oxygen
12 Regulators approve expanded emergency use of Eli Lilly's COVID-19 treatment
13 Eli Lilly pens pact with Banner Alzheimer's Institute for 'virtual approach' for its late-stage donanemab test
14 Eli Lilly releases data showing potential of donanemab in lowering Alzheimer’s pathology
15 Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
16 Eli Lilly opens Olympic Games with first corporate ad—and a reality check on the state of the U.S. health system
17 Now Christians are attacking Eli Lilly for being too diverse
18 Could Eli Lilly Successfully Treat Heart Failure With Its Diabetes Drug?
19 Solar farm of 5.6 MW, Ireland's largest, launched at Eli Lilly plant
20 Lilly Group Partnering with California Company
21 Eli Lilly snags 102 acres in Research Triangle Park, plans expansion
22 Eli Lilly makes modest bet on 'all-in-human' discovery outfit for ALS drugs, deepening bid in precision neurology
23 Eli Lilly's $15M investment deepens link to startup developing new class of RNA meds
24 Eli Lilly & Co. stock underperforms Tuesday when compared to competitors despite daily gains
25 Eli Lilly partner AbCellera finds a CBO in the face of bamlanivimab struggles; FibroGen's next CSO walks into roxadustat rebuff
26 Is Eli Lilly a Better Alzheimer's Stock Than Biogen?
27 Mayo Clinic: Eli Lilly, Regeneron antibodies help COVID-19 patients avoid the hospital
28 Eli Lilly, Verge Partner to Identify and Test Potential ALS Therapies
29 Eli Lilly acquires another 102 acres in RTP for ‘future expansion possibility’
30 UPDATED: Eli Lilly swoops in to buy a small protein drug developer and its glucose responsive insulin in $1B-plus deal
31 Do Eli Lilly's (NYSE:LLY) Earnings Warrant Your Attention?
32 Eli Lilly: A Dark Past of Cruel Experiments on Animals
33 Major Indianapolis firms plan return to office — but delta variant looms
34 Regeneron, GlaxoSmithKline and Eli Lilly COVID-19 drugs prioritized for expedited review in Europe
35 Eli Lilly expansion has potential to create new jobs in Cork
36 Eli Lilly partners with Alzheimer's center for PhIII study; New tuberculosis consortium emerges in $218M+ project
37 Eli Lilly, Boehringer Ingelheim's Jardiance posts 'blockbuster' heart failure win, setting up 2021 filings
38 Eli Lilly & Co. stock rises Friday, outperforms market
39 Domino’s, Eli Lilly, McDonald’s, Merck and More Tuesday Afternoon Analyst Upgrades and Downgrades
40 Analysts Offer Predictions for Eli Lilly and Company's Q2 2021 Earnings (NYSE:LLY)
41 'Aduhelm left room': Lilly CEO eyes competition with rival Alzheimer's drug
42 The Zacks Analyst Blog Highlights: Eli Lilly, Pfizer, BioNTech and Bayer
43 Eli Lilly and Novo Nordisk set to dominate GLP-1RA market
44 Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
45 With Eli Lilly's backing, a team of Seagen veterans with ADC chops is looking to crash the Chinese oncology party
46 FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
47 Whistleblower loses bid to revive Bayer, Eli Lilly cases over DOJ's objections
48 Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
49 Look out, Lilly: Biogen's Aduhelm likely won't be the only Alzheimer's med subject to Medicare's coverage review
50 Erectile Dysfunction Devices To See Steady Growth During, Key Players – Eli Lilly, Dong-A Socio. – Domestic Violence
51 AbbVie, Lilly atopic dermatitis hopefuls hit with more delays as FDA's JAK inhibitor holdups carry on
52 Eli Lilly and (LLY) Set to Announce Earnings on Tuesday
53 FCA upholds reconsideration decision maintaining $100M+ award against Apotex for cefaclor patent infringement
54 Friday's business headlines
55 Biden unveils vaccine plan for federal employees
56 Global Fibromyalgia Drugs Market Report 2021-2027 | Daiichi Sankyo, Eli Lilly, Innovative Med Concepts, Pfizer – Your Subsea News
57 As COVID-19 cases surge, Lilly reinstates mask restrictions on all workers
58 Erectile Dysfunction Market Is Booming Worldwide | Eli Lilly, Pfizer, Bayer and more – Domestic Violence
59 Insulin Market Challenges Eli Lilly, Novo Nordisk, Biocon, etc.: Increased Business Risk after COVID-19 – The Manomet Current
60 Autoinjectors Market Size, Key Players Analysis and Forecast To 2027 : Eli Lilly, Abbvie, Biogen, Teva, Mylan, Merck, Ypsomed, SHL Group, Becton Dickinson and Company – The Manomet Current
61 Global Malignant Pleural Mesothelioma Treatment Market-Competitive Insights: Eli Lilly and Company, AstraZeneca plc, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH – The Manomet Current
62 Global Cutaneous Squamous Cell Carcinoma Treatment 2021-Competitive Insights:Eli Lilly and Company, Sanofi SA, Cadila Healthcare Limited, Cipla Limited, Castle Biosciences, Regeneron Pharmaceuticals, – The Manomet Current
63 Eli Lilly and Company
64 Human Insulin Market Structure, Industry Inspection, Forecast 2027| Eli Lilly, Novo Nordisk, Sanofi – Domestic Violence
65 Pharma Stock Roundup: Q2 Earnings of MRK, PFE & Others, FDA Approvals for GSK, ABBV
66 Market Assessment of Raloxifene Hydrochloride Tablets Industry: Growth Drivers by Top Players like Eli Lilly, Apotex Corporation, Teva Pharmaceutical, Jiangsu Hengrui Medicine, Aurobindo Pharma, Sciegen Pharmaceuticals, and more | Affluence – Domesti
67 Global Urological Cancer Therapeutics Drugs Market: AstraZeneca plc, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi SA, F. Hoffmann-La Roche AG, Novartis, Allergan Inc – The Manomet Current
68 Autism Disorder And Treatment Market Thundering Growth with Key Players – Eli Lilly and Company, Intra-Cellular Therapies Inc. – Domestic Violence
69 Due for a Growth: Eli Lilly and Company (LLY), NGL Energy Partners LP (NGL)
70 The Latest: State extends emergency designation | Biden orders vaccine rules for federal workers
71 Takeda and Frazier team up again to launch a spinout — this time focused on a late-stage vaccine
72 Learn to Evaluate Eli Lilly (LLY) using the Charts
73 Hartford Seminary receives $5 million Lilly Endowment grant
74 Growth Drivers of Targeted Cancer Drugs Market with Relevancy Mapping by Key Player like Pfizeryte, Novartis, Eli Lilly, Gilead, Sanofi, AbbVie, and more | Forecast 2021-2026 – Domestic Violence
75 Cefuximab Market Size, Status and Global Outlook 2021 to 2025| Eli Lilly, Merck – The Manomet Current
76 Top Gilead cancer researcher jumps to a startup as Dan Chen exits; Ardelyx gets that CRL we've been waiting for
77 Erectile Dysfunction Drugs Market to Witness Growth Acceleration | Vivus, Inc., Eli Lilly and Company, Inc., Bayer AG – The Manomet Current
78 BeiGene looks to carve out more space in the US market, setting up BTK drug for 2nd blood cancer nod
79 Hormone Replacement Therapy Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Eli Lilly, Teva, Novo Nordisk, Pfizer, Bayer, AbbVie, Abbott, Mylan, Merck KGaA,… – Domestic Violence
80 Eli Lilly fires back against HHS order to repay providers for violating 340B
81 Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals
82 Eli Lilly CEO says drugmaker will keep looking for ways to cut insulin costs as Walmart debuts lower-price rival
83 Eli Lilly will reopen with 25% of employees on June 1 and fully reopen July 12
84 Blood Glucose Monitoring Devices Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Eli Lilly and Company, Sanofi, Dexcom, Inc., Braun Melsungen AG, Lifescan, … – Domestic Violence
85 Eli Lilly Modifies COVID-19 Purchase Agreement with the US Government
86 FDA's oncology head Rick Pazdur defends the accelerated approval pathway, claiming it is 'under attack'
87 Eli Lilly faces employee complaints, FDA troubles at factory making COVID-19 drug: report
88 Arthur M. Cohen & Associates, Llc Buys Eli Lilly and Co, Vanguard High Dividend Yield Indx
89 Eli Lilly faces federal investigation at New Jersey plant that produces COVID therapy
90 Eli Lilly hit with DOJ subpoena over New Jersey factory making COVID-19 drug
91 US government stops distribution of Eli Lilly Covid-19 antibody treatment due to spread of coronavirus variants
92 Eli Lilly to Seek FDA Approval for Alzheimer’s Drug
93 Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for Covid drugs
94 Eli Lilly Stock Falls After Alzheimer's Drug Results Disappoint Wall Street
95 Eli Lilly Responds to Sanitation and Quality Control Concerns
96 Distribution of Eli Lilly COVID-19 therapy paused in 8 states over variant concerns
97 Eli Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
98 Eli Lilly and Welldoc to Collaborate on New Digital Insulin Management Solution
99 US pauses use of Eli Lilly Covid-19 mAb combo in six more states due to variants from Brazil, India
100 Eli Lilly Will Unveil Alzheimer's Drug Data Next Week. What to Watch.